Callan JMB (CJMB)
Emergency-readiness logistics and temperature-controlled packaging for medical supply chains.
Something off on this page? Send us feedback.
Provides emergency-readiness logistics and temperature-controlled packaging, fulfillment, monitoring, and recovery services for public-health and life-sciences customers. Most revenue comes from service work, and the U.S.-centered, single-segment business depends heavily on government contracts and a concentrated customer base.
Manages medical stockpiles, readiness planning, emergency deployments, quality control, and temperature-sensitive fulfillment for state and local government customers. It also provides reusable temperature-regulating packaging paired with ordering, inventory, pick/pack, tracking, and recovery services for medical and other sensitive products.
Runs a U.S.-centered, single-segment business through service centers and warehouses, using Sentry monitoring, IMS inventory and shipment tools, and SHIP2Q packaging recovery. Revenue is primarily service-based and recognized as work is performed, while packaging revenue is recognized on delivery.
Depends heavily on a small group of customers and government contracts, along with component suppliers, carrier relationships, regulatory compliance, and reliable data systems.
Company facts
Categories
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $860.3K · Total debt $2.1M · Total assets $4.5M · Shareholders' equity $681.9K
- Revenue
- $1.4M
- Operating income
- −$1.3M
- Net income
- −$1.2M
No dividends on record.
| Institutions12 holders · as of Mar 31, 2026 | 12.58% | 600.9K shares | |
| Insiders4 holders · as of Jun 1, 2026 | 81.95% | 3.92M shares | |
| Otherremainder | 5.47% | 261.7K shares |
4.78M company shares as of Aug 27, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (5.75M in the company's Sep 3, 2026 report, 4.78M elsewhere); stakes use the report.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Evidence |
|---|---|---|---|
Wayne D. WilliamsInsiderdirector, 10 percent owner, officer: CEO, Chairman and President | 49.22% | 2.35M | Form 4filed Dec 18, 2025 ↗ |
David J. CroyleInsider10 percent owner, officer: Chief Medical Officer | 32.44% | 1.55M | Form 4filed Mar 26, 2026 ↗ |
Creative PlanningInstitution | 5.35% | 255,693 | 13Fas of Mar 31, 2026 |
Bard Associates IncInstitution | 5.14% | 245,482 | 13Fas of Mar 31, 2026 |
Jane Street Group, LLCInstitution | 0.59% | 28,263 | 13Fas of Mar 31, 2026 |
| See all 16 → | |||
13F — a manager's quarterly holdings · Form 4 — an insider's transaction report
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Dec 30, 2025 | Gerald Dial | director | +12,000 | $0.8358 |
| Mar 20, 2026 | David J. Croyle | 10 percent owner, officer: Chief Medical Officer | +10,195 | $1.75 |
| Mar 6, 2026 | David J. Croyle | 10 percent owner, officer: Chief Medical Officer | +14,805 | $1.76 |
| Dec 16, 2025 | Wayne D. Williams | director, 10 percent owner, officer: CEO, Chairman and President | +5,000 | $1.73 |
| Dec 15, 2025 | Wayne D. Williams | director, 10 percent owner, officer: CEO, Chairman and President | +10,810 | $1.70 |
